Navigation Links
VHGI: VHGI Gold Targets Candidates to Fill Key Advisory Board Position to Evaluate International Mining Acquisitions; Internet Town Hall Meeting Details Emerge, Kitco Gold Coverage Initiated
Date:12/17/2009

ations made to VHGI which ultimately came from the owner of the subject property and their associates. The United States Securities and Exchange Commission permits mining companies, in their filings with the SEC, to disclose only those mineral deposits that a company can economically and legally extract or produce. We use certain terms on this website, such as "reserves," "resources," "geologic resources," "proven," "probable," "measured," "indicated," and "inferred," that the SEC guidelines strictly prohibit us from including in our filings with the SEC.

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.


    For Further Information:
    Shareholder Relations - Communications    859-514-6982

SOURCE Virtual Health Technologies, Inc.


'/>"/>
SOURCE Virtual Health Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled
2. Researchers identify proteins in lung cancer cells that may provide potential drug targets
3. Toronto Conference Targets the Vitamin D Deficiency Crisis
4. Hard to Treat Diseases Inc. (HTDS) Targets an EU Based Stem Cell Research Company for a Merger
5. URI research couples method targets cancerous tumors
6. Revolutionary statewide UC collaboration targets breast cancer
7. Workshop targets control-theoretic approaches for agent-based models
8. GENova Biotherapeutics secures new cancer drugs targets
9. Mayo Clinic identifies 2 genes as potential therapeutic targets for multiple sclerosis
10. LSUHSC research discovers new targets for treatment of invasive breast cancer
11. Compound Targets, Destroys Cancer Stem Cells in Mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2015)... San Rafael, CA (PRWEB) May 25, 2015 ... Field for a free two-hour instructional clinic. Irish National ... with campers and give them a taste of her coaching ... San Anselmo and Novato. Camps in Novato are at Lynwood ... 3). , Novato High School - June 6th, 2015 ...
(Date:5/25/2015)... May 25, 2015 Tunstall Americas announces ... the highest level of service to its Medical Answering ... and a restructuring of resources, Tunstall now provides a ... the Medical Answering Service to ensure superior patient satisfaction. ... it has invested over $10 million in expanded facilities ...
(Date:5/25/2015)... Dallas, TX (PRWEB) May 25, 2015 Decora ... renowned company ‘Leviton’ is now available on ‘The Hardware City.’ ... A user has to set a time and the related ... , When contacted a representative of the company said, “We ... ‘The Hardware City.’ Now customers can buy Countdown Timer Switch ...
(Date:5/24/2015)... May 24, 2015 The Rolling Stones ... 24th in San Diego at Petco Park. This iconic ... On May 20th, they had a warmup show in ... preview show in Los Angeles, this beloved band not only ... played fan favorites such as "Jumping Jack Flash," "Moonlight ...
(Date:5/24/2015)... May 24, 2015 For people who ... Chinese Enterokinase Industry, 2009-2019 Market Research Report would be ... an exhaustive study on the present market scenario of ... into the growing Chinese market of this industry. The ... overall status of the manufacturers in this industry. The ...
Breaking Medicine News(10 mins):Health News:US Sports Camps and Nike Soccer Camps Offer Complimentary Instructional Clinic with Fiona's Soccer Camp 2Health News:Tunstall Introduces New Medical Answering Service for the 21st Century Practice 2Health News:Leviton's Decora 60 Minute Countdown Timer Available On ‘The Hardware City’ 2Health News:The Rolling Stones Tickets in San Diego, Orlando, Minneapolis, Dallas, Pittsburgh, Indianapolis, Atlanta, Detroit, Milwaukee, Kansas City, Columbus, Nashville & Raleigh 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4
... New Accounts Sign On; Existing Accounts Expand , , ... practice management, announces impressive growth in the first quarter of ... addition to customer add-ons continues to drive Ingenious Med,s success ... Med originated as a company dedicated to hospitalist revenue-cycle, but ...
... , , Group led by conservative political ... , WASHINGTON, June 1 Public Campaign Action Fund issued ... Care Ads" to expose the group behind the political ads ... reform. The ads are funded by the Americans for Prosperity ...
... , MONDAY, June 1 (HealthDay News) -- Putting patients ... frequent detection of precancerous polyps than merely making patients ... colonoscopy, patients can either be put to sleep under ... which allows them to hear and respond to directions ...
... 1 ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), ... and Drug Administration (FDA) that the Dermatologic and Ophthalmic Drugs ... Bepreve(TM) (bepotastine ophthalmic solution) on June 26, 2009. , ... its NDA with the FDA for Bepreve as an eye ...
... New Web-based community will increase collaboration and resource-sharing in ... YORK, June 1 The Michael J. Fox Foundation ... Research ( pdonlineresearch.org ), a resource-rich virtual workplace that ... PD researchers and funders collaborating and conversing across the ...
... other name is still a rose, but is an ... ,jock, are sometimes used interchangeably, but they are really ... Buffalo researcher Kathleen E. Miller, Ph.D. "In terms of ... these two identities represent very different perspectives and may ...
Cached Medicine News:Health News:Ingenious Med Experiences Impressive Growth in First Quarter 2009 2Health News:Ingenious Med Experiences Impressive Growth in First Quarter 2009 3Health News:"Viewers Beware" Report by Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running in Indiana 2Health News:Deep Sleep May Improve Colonoscopy Results 2Health News:ISTA Pharmaceuticals Announces FDA Advisory Committee to Review Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis 2Health News:ISTA Pharmaceuticals Announces FDA Advisory Committee to Review Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis 3Health News:Michael J. Fox Foundation Announces Launch of PD Online Research 2Health News:Michael J. Fox Foundation Announces Launch of PD Online Research 3Health News:Don't mistake an athlete for a 'toxic jock' 2
(Date:5/22/2015)... May 22, 2015   InspireMD, Inc. (NYSE MKT: ... protection systems ("EPS"), today announced that its CGuard TM ... principle investigator Prof. Piotr Musialek , at the ... Paris, France . PARADIGM, an investigator-initiated ... c A roti D revascularization I n symptomatic ...
(Date:5/22/2015)... R.I. , May 22, 2015 ... once-daily central nervous system stimulant indicated for the ... to patients beginning Summer 2015. ... XR received approval from the U.S. Food and ... is an extended-release formulation of methylphenidate capsule with ...
(Date:5/22/2015)... Richmond Pharmacology is a ... a worldwide reputation for excellence in clinical trials. ... peer reviewed medical journals. Its officers are engaged ... discussions about rules for transparency and publication of ... , Clinical research is conducted worldwide, ...
Breaking Medicine Technology:InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6
... Data Presented on Valopicitabine Combined,with an Investigational ... /PRNewswire-FirstCall/ --,Idenix Pharmaceuticals, Inc. today announced results ... combination of valopicitabine (NM283) and,pegylated interferon alfa-2a ... infected with the genotype-1,strain of the hepatitis ...
... 11, 2007 /PRNewswire-FirstCall/ --,Advanced Magnetics today announced ... trials of ferumoxytol as an,intravenous (IV) iron ... approximately 6:00 pm EDT as posters at ... Orlando,Florida. These posters are available in the ...
Cached Medicine Technology:Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 2Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 3Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 4Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 5Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 6Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 7Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 2Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 3Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 4Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 5Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 6Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 7Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 8
... The new DeVilbiss PulmoAide Compact Compressor provides effective ... size allows for therapy at home or on ... 5-year warranty, and the same reliable operation you ... ,The PulmoAide Compact Compressor is the perfect solution ...
The 16 liter Laparoscopy Insufflator combines high safety and precise pressure control with simple operation....
Stryker's 40-liter insufflator provides superior performance with unprecedented safety and reliability....
ACMI™ COAG Bipolar Laparoscopy Probes provide 360 of hemostatis, bipolar safety, blunt dissection, irrigation, and suction in one instrument....
Medicine Products: